Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Jun 2024 for OptimizeRx Corp. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Gus d. Halas: trading record in brief
This profile gathers the share dealings of Gus d. Halas across 2 companies, led by OptimizeRx Corp and Hooper Holmes Inc. Between 25 January 2016 and 5 June 2024, the trades on record add up to 7 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 11 June 2024 came the latest disclosure, an option exercise in OptimizeRx Corp. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gus d. Halas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
10,061 shares0Common StockSEC:0001628280-24-027712:0
4,637 shares0Common StockSEC:0001628280-23-029934:0
657 shares0Common StockSEC:0001628280-23-010322:0
409 shares0Common StockSEC:0001628280-23-000220:0
334 shares0Common StockSEC:0001628280-22-025810:0
407 shares0Common StockSEC:0001213900-21-035076:0
500,000 sharesCommon StockSEC:0001127602-16-038561:0
7 of 7 declarations
